297 related articles for article (PubMed ID: 18285686)
1. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature.
Sanli H; Akay BN; Arat M; Koçyigit P; Akan H; Beksac M; Ilhan O
Dermatology; 2008; 216(4):349-54. PubMed ID: 18285686
[TBL] [Abstract][Full Text] [Related]
2. Acquired ichthyosis associated with chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia.
Dilek I; Demirer T; Ustün C; Arat M; Koç H; Beksaç M; Erdi H; Anadolu R; Ozcan M; Ilhan O; Akan H
Bone Marrow Transplant; 1998 Jun; 21(11):1159-61. PubMed ID: 9645582
[TBL] [Abstract][Full Text] [Related]
3. Severe oral chronic graft-versus-host disease following allogeneic bone marrow transplantation: highly effective treatment with topical tacrolimus.
Eckardt A; Starke O; Stadler M; Reuter C; Hertenstein B
Oral Oncol; 2004 Sep; 40(8):811-4. PubMed ID: 15288836
[TBL] [Abstract][Full Text] [Related]
4. Vitiligo as a post-bone marrow transplantation complication.
Cathcart S; Morrell D
J Pediatr Hematol Oncol; 2007 Jul; 29(7):485-7. PubMed ID: 17609627
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
Chiang CC; Lin JM; Chen WL; Tsai YY
Cornea; 2007 Aug; 26(7):861-3. PubMed ID: 17667623
[TBL] [Abstract][Full Text] [Related]
6. HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for chronic myeloid leukemia: improved outcomes in patients in accelerated phase and blast crisis phase.
Xiao-Jun H; Lan-Ping X; Kai-Yan L; Dai-Hong L; Huan C; Wei H; Yu-Hong C; Jing-Zhi W; Yao C; Xiao-Hui Z; Hong-Xia S; Dao-Pei L
Ann Med; 2008; 40(6):444-55. PubMed ID: 18608121
[TBL] [Abstract][Full Text] [Related]
7. Generalized vitiligo after allogeneic bone marrow transplantation.
Cho SB; Roh MR; Chung KY; Lee KH; Park YK
Acta Derm Venereol; 2005; 85(1):82-3. PubMed ID: 15849005
[No Abstract] [Full Text] [Related]
8. Graft-versus-adult T-cell leukemia/lymphoma effect following allogeneic hematopoietic stem cell transplantation.
Yonekura K; Utsunomiya A; Takatsuka Y; Takeuchi S; Tashiro Y; Kanzaki T; Kanekura T
Bone Marrow Transplant; 2008 Jun; 41(12):1029-35. PubMed ID: 18332910
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
10. Ocular findings after allogeneic hematopoietic stem cell transplantation.
Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous graft-versus-host disease: a guide for the dermatologist.
Häusermann P; Walter RB; Halter J; Biedermann BC; Tichelli A; Itin P; Gratwohl A
Dermatology; 2008; 216(4):287-304. PubMed ID: 18230976
[TBL] [Abstract][Full Text] [Related]
12. Complete vaginal obstruction with hematometra after hematopoietic stem cell transplantation for chronic myeloid leukemia: a case report.
Rodolakis A; Thomakos N; Harhalakis N; Iconomou T; Antsaklis A
J Reprod Med; 2007 Oct; 52(10):959-61. PubMed ID: 17977175
[TBL] [Abstract][Full Text] [Related]
13. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
14. Extensive chronic graft-versus-host disease of skin successfully treated with thalidomide.
Nair V; Sharma A; Ghosh I; Arora S; Sahai K; Dutta V
J Assoc Physicians India; 2005 Nov; 53():988-90. PubMed ID: 16515241
[TBL] [Abstract][Full Text] [Related]
15. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
[TBL] [Abstract][Full Text] [Related]
16. Autoimmunity following haematopoietic stem-cell transplantation.
Daikeler T; Tyndall A
Best Pract Res Clin Haematol; 2007 Jun; 20(2):349-60. PubMed ID: 17448966
[TBL] [Abstract][Full Text] [Related]
17. Pemphigoid-like ocular lesions in patients with graft-versus-host disease following allogeneic bone marrow transplantation.
Karwacka E; Ołdakowska-Jedynak U; Brydak-Godowska J; Paczek L; Kecik D
Transplant Proc; 2006; 38(1):292-4. PubMed ID: 16504728
[TBL] [Abstract][Full Text] [Related]
18. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
Kim HJ; Min WS; Cho BS; Eom KS; Kim YJ; Min CK; Lee S; Cho SG; Jin JY; Lee JW; Kim CC
Biol Blood Marrow Transplant; 2009 Jun; 15(6):704-17. PubMed ID: 19450755
[TBL] [Abstract][Full Text] [Related]
19. Individual physician practice variation in hematopoietic cell transplantation.
Lee SJ; Joffe S; Artz AS; Champlin RE; Davies SM; Jagasia M; Kernan NA; Loberiza FR; Soiffer RJ; Eapen M
J Clin Oncol; 2008 May; 26(13):2162-70. PubMed ID: 18378566
[TBL] [Abstract][Full Text] [Related]
20. Generalized vitiligo after lymphocyte infusion for relapsed leukaemia.
Au WY; Yeung CK; Chan HH; Lie AK
Br J Dermatol; 2001 Dec; 145(6):1015-7. PubMed ID: 11899125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
